GlassScriptPhysician profile
Arvindh N Kanagasundram
NPI 1932381795
$161,374.21
in general payments reported to CMS, 2019-2025
12 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $16K · 2021: $4,753 · 2022: $6,041 · 2023: $43K · 2024: $34K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $39K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Food and Beverage: $3,207 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,825.00 |
| Travel and Lodging | $39,028.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Food and Beverage | $3,207.43 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $102,694.07 | 2019-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Amplatzer |
| Janssen Pharmaceuticals, INC | $33,749.28 | 2019-2020 | |
| Medical Device Business Services, INC. | $11,061.50 | 2019-2021 | |
| Biosense Webster, INC. | $9,053.31 | 2020-2025 | Carto 3, Thermocool Sf |
| Adagio Medical, INC. | $2,404.56 | 2022 | |
| Biotronik INC. | $927.52 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $836.53 | 2019 | |
| Medtronic, INC. | $320.39 | 2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Pfizer INC. | $128.79 | 2019-2023 | |
| Atricure, INC. | $123.33 | 2023 | |
| Boston Scientific Corporation | $74.93 | 2025 | General - Therapies |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvindh Kanagasundram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.